These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10711789)

  • 21. Total radical-trapping antioxidant potential (TRAP) of plasma: effects of supplementation of young healthy volunteers with large doses of alpha-tocopherol and ascorbic acid.
    Mulholland CW; Strain JJ
    Int J Vitam Nutr Res; 1993; 63(1):27-30. PubMed ID: 8320055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxygen-radical absorbance capacity assay for antioxidants.
    Cao G; Alessio HM; Cutler RG
    Free Radic Biol Med; 1993 Mar; 14(3):303-11. PubMed ID: 8458588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total free radical trapping antioxidant potential in pre-eclampsia.
    Kharb S
    Int J Gynaecol Obstet; 2000 Apr; 69(1):23-6. PubMed ID: 10760528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilirubin and ascorbate antioxidant activity in neonatal plasma.
    Gopinathan V; Miller NJ; Milner AD; Rice-Evans CA
    FEBS Lett; 1994 Aug; 349(2):197-200. PubMed ID: 8050565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
    Langley SC; Brown RK; Kelly FJ
    Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High plasma vitamin C concentrations at birth associated with low antioxidant status and poor outcome in premature infants.
    Silvers KM; Gibson AT; Powers HJ
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F40-4. PubMed ID: 8092870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients.
    Erhola M; Nieminen MM; Kellokumpu-Lehtinen P; Huusari H; Alanko K; Metsä-Ketelä T; Alho H
    J Exp Clin Cancer Res; 1998 Jun; 17(2):219-25. PubMed ID: 9700584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study.
    Erhola M; Nieminen MM; Ojala A; Metsä-Ketelä T; Kellokumpu-Lehtinen P; Alho H
    J Exp Clin Cancer Res; 1998 Sep; 17(3):325-30. PubMed ID: 9894770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids.
    Hara K; Yamashita S; Fujisawa A; Ishiwa S; Ogawa T; Yamamoto Y
    Biochem Biophys Res Commun; 1999 Apr; 257(1):244-8. PubMed ID: 10092541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total radical-trapping antioxidant parameter in NIDDM patients.
    Ceriello A; Bortolotti N; Falleti E; Taboga C; Tonutti L; Crescentini A; Motz E; Lizzio S; Russo A; Bartoli E
    Diabetes Care; 1997 Feb; 20(2):194-7. PubMed ID: 9118773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of selenium status to respiratory outcome in the very low birth weight infant.
    Darlow BA; Inder TE; Graham PJ; Sluis KB; Malpas TJ; Taylor BJ; Winterbourn CC
    Pediatrics; 1995 Aug; 96(2 Pt 1):314-9. PubMed ID: 7630691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. F2-isoprostanes and total radical-trapping antioxidant potential in preterm infants receiving parenteral lipid emulsions.
    Roggero P; Mosca F; Giannì ML; Orsi A; Amato O; Migliorisi E; Longini M; Buonocore G
    Nutrition; 2010 May; 26(5):551-5. PubMed ID: 19880291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascorbate is an outstanding antioxidant in human blood plasma.
    Frei B; England L; Ames BN
    Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6377-81. PubMed ID: 2762330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mean platelet volume in very preterm infants: a predictor of morbidities?
    Cekmez F; Tanju IA; Canpolat FE; Aydinoz S; Aydemir G; Karademir F; Sarici SU
    Eur Rev Med Pharmacol Sci; 2013 Jan; 17(1):134-7. PubMed ID: 23329535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients.
    Erhola M; Kellokumpu-Lehtinen P; Metsä-Ketelä T; Alanko K; Nieminen MM
    Free Radic Biol Med; 1996; 21(3):383-90. PubMed ID: 8855450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
    Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the safety of ascorbic acid administration to the premature infant.
    Bass WT; Malati N; Castle MC; White LE
    Am J Perinatol; 1998 Feb; 15(2):133-40. PubMed ID: 9514139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of biomarkers of oxidative stress and antioxidant capacity in the cord blood of preterm low birth weight neonates.
    Negi R; Pande D; Kumar A; Khanna RS; Khanna HD
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1338-41. PubMed ID: 22046974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an exchange transfusion on plasma antioxidants in the newborn.
    Lindeman JH; Lentjes EG; Houdkamp E; van Zoeren-Grobben D; Schrijver J; Berger HM
    Pediatrics; 1992 Aug; 90(2 Pt 1):200-3. PubMed ID: 1641283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant activity, packed cell transfusions, and outcome in premature infants.
    Silvers KM; Gibson AT; Russell JM; Powers HJ
    Arch Dis Child Fetal Neonatal Ed; 1998 May; 78(3):F214-9. PubMed ID: 9713035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.